Rigel Pharmaceuticals, Inc. (RIGL)
27.36
-0.17
(-0.62%)
USD |
NASDAQ |
Apr 06, 16:00
27.30
-0.06
(-0.24%)
After-Hours: 20:00
Rigel Pharmaceuticals SG&A Expense (TTM) : 115.90M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Eli Lilly & Co. | 11.09B |
| Nektar Therapeutics | 68.67M |
| Ironwood Pharmaceuticals, Inc. | 82.26M |
| BioMarin Pharmaceutical, Inc. | 1.153B |
| Amicus Therapeutics, Inc. | 383.49M |